Regulation of device effectiveness by FDA should be eliminated, Rep. Barton suggests.
This article was originally published in The Gray Sheet
SEN. HATCH PREFERS "INCREMENTAL" APPROACH TO FDA REFORM, Tricia Knight, health director for the Utah Republican, indicated at the Medical Device Manufacturers Association May 12 during the group's annual meeting in Washington, D.C. Discussing FDA reform initiatives currently under way on Capitol Hill, Knight said that "large proposals don't have as much of a chance as small proposals...in part because of so many competing interests. Incremental reforms may have more of a chance."
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.